Skip to content
Briefings are running a touch slower this week while we rebuild the foundations.See roadmap
UK Startups and Innovation
29MAY

Orbital's $50m has no UK lead

2 min read
14:17UTC

Orbital Industries closed $50m on 28 May with Plural and NVIDIA's NVentures, the third ex-DeepMind London mega-round in 18 months with no British lead investor. The same week Balderton led Geordie's $30m and the state-backed British Business Bank put £50m into a deeptech fund writing sub-£2m cheques. Britain's record VC year is a barbell, not a boom.

Key takeaway

UK capital runs the seed floor and the mega-round top; the £2m-to-£20m growth middle belongs to foreigners.

This briefing mapped
Loading map…
Economic
Diplomatic

Orbital Industries closed a $50m Series B on 28 May led by Europe's Plural with NVIDIA's NVentures; not one pound came from a UK fund. The talent is British, the growth equity is not.

Sources profile:This story draws on neutral-leaning sources

Geordie raised a $30m Series A on 28 May led by London's Balderton Capital, building runtime security for AI agents. A UK fund led a category that did not exist 18 months ago.

Sources profile:This story draws on neutral-leaning sources

Geordie, a London startup that monitors AI agents inside corporate networks, raised a $30m Series A on 28 May led by Balderton Capital. Its founders came from Darktrace and Snyk, and revenue grew 1,300% in five months.

Geordie follows the early path of Darktrace, a security category that incumbents dismissed until growth forced a rethink. It must now scale alone or get acquired before rivals catch up. 

The British Business Bank put a £50m cornerstone into Longwall Ventures Fund 4 on 27 May. Below £2m, the only institutional anchor a deeptech round can now count on is the state.

Sources profile:This story draws on neutral-leaning sources

The British Business Bank put £50m into Longwall Ventures Fund 4 on 27 May, a fund writing £500,000 to £2m cheques into early-stage deeptech. UK venture funding hit $10.5bn in early 2026, yet deal volume fell 2%.

The money pooled into a few giant rounds while smaller firms saw nothing. The bank now backstops the tier private investors left after April's cut to venture trust tax relief. 

Bristol's Mykor raised £4m on 27 May to grow building panels from mycelium, with £337m in orders signed before the first panel ships. Demand proven ahead of production, the opposite of most cleantech risk.

Sources profile:This story draws on neutral-leaning sources

Mykor, a Bristol startup, raised £4m on 27 May led by the Clean Growth Fund. It grows building insulation panels from mushroom roots and farm waste, cutting embodied carbon by 60%, and has already signed £337m in pre-orders.

Contractors signed those orders before the first panel ships, reversing the usual cleantech risk. A regional firm with proven demand shows the funding boom reaches beyond London AI. 

Liz Kendall signed the UK-France Strategic Biomedical Alliance on 29 May, the first bilateral science deal of its kind since Brexit, linking Bristol's Isambard-AI supercomputer to France's GENCI.

Sources profile:This story draws on mixed-leaning sources from United Kingdom (includes United Kingdom state media)
United Kingdom

Science Secretary Liz Kendall signed the UK-France biomedical alliance on 29 May, the first bilateral science deal of its kind since Brexit. The UK put £894,000 into linking its Isambard-AI supercomputer in Bristol with France's national supercomputing centre.

Researchers on both sides gain shared computing power and funded exchanges. Modest in cash terms, the deal rebuilds science ties below the level of full EU-wide negotiation. 

Closing comments

Concentration trend is rising. Capital is pooling into fewer, larger rounds while deal volume falls, a pattern that will deepen unless a new domestic instrument addresses the £2m-£20m middle. The specific trigger to watch is the SAIU Strategic Assets Grants announcement on 5 June: if the instruments named there reach below £20m into growth-stage deeptech, the bifurcation has a partial corrective. If they replicate the sovereign-vehicle pattern of targeting AI hardware above £20m, the gap widens into the next funding cycle. The Longwall Fund 4 final close (December target) is the parallel test for the seed tier: if private LPs follow the BBB cornerstone to close the £13.8m gap to £100m, the ECF model has proven it can attract follow-on capital. If the close extends past December or falls short, the state-anchor model faces a legitimacy question.

Different Perspectives
UK Government (DSIT / British Business Bank)
UK Government (DSIT / British Business Bank)
The BBB cornerstoned Longwall at the seed floor on 27 May while DSIT signed the UK-France bilateral compute deal the same week, deploying state capital at bottom and research layers simultaneously. Neither instrument addresses the Series B middle the April 2026 mandate expansion could reach but has not.
US growth investors (NVentures, General Catalyst, Crosspoint Capital)
US growth investors (NVentures, General Catalyst, Crosspoint Capital)
NVentures entering Orbital's cap table for the first time and General Catalyst following on in Geordie's Series A signals US growth investors treating London deeptech as a buy-side opportunity the UK market cannot contest. NVentures gains supply-chain visibility into GPU cooling; General Catalyst gains a frontier security category the RSAC prize has already validated for US enterprise.
France (DSIT / GENCI / Institut Pasteur)
France (DSIT / GENCI / Institut Pasteur)
France signed the UK-France Strategic Biomedical Alliance on 29 May, contributing €330,000 a year to researcher mobility and linking GENCI national compute to Isambard-AI; the bilateral format suits Paris because it produces scientific access without requiring EU-framework ratification while the UK-EU science relationship remains unsettled.
European limited partners (Plural, Aviva Investors)
European limited partners (Plural, Aviva Investors)
Pan-European fund Plural led Orbital's $50m and Aviva Investors co-anchored the BBB's Lansdowne spinout fund (event ID:3505), demonstrating that Continental and UK institutional capital can fill the growth-stage tier independently, though neither has the scale to compete with US growth funds at the $100m+ band that successive ex-DeepMind rounds will eventually reach.